V.F. Chekhun, O.O. Lykhova, N.O. Bezdieniezhnykh, D.V. Kukurudza, V.G. Lupan
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine



Summary. Aim: to investigate the influence of human microbiota element Lactobacillus rhamnosus on the viability, proliferation and apoptosis of breast cancer (BC) cells with various degrees of malignancy in vitro. Objects and methods: human breast cancer cells of the MCF-7, T47D and MDA-MB-231 lines, as well as live and pasteurized bacteria cells of Lactobacillus rhamnosus or their secreted metabolites, were used as research objects. The expression of proteins associated with the proliferation and apoptosis regulation in breast cancer cells was assessed by immunocytochemical analysis. Results: the direct interaction of Lactobacillus rhamnosus live cells and BC cells leads to the most significant effect on the viability and proliferation of malignant cells, compared to the action of their secreted metabolites (contactless cocultivation in the Insert system) or pasteurized microorganisms. Incubation of luminal-type breast cancer cells with Lactobacillus rhamnosus was accompanied by suppression of the proliferation marker Ki-67expression. Co-cultivation of T47D cells and Lactobacillus rhamnosus led to increased expression of both the pro-apoptotic proteins Bax and p21WAF1, as well as the anti-apoptotic protein Bcl-2. In MCF-7 cells lactobacilli increased the expression of p21WAF1, but did not affect the expression of Bcl-2. In MDA-MB-231 cells, which are characterized by the highest degree of malignancy, Lactobacillus rhamnosus caused only an increase in the anti-apoptotic marker Bcl-2 expression. Conclusions: in human ВС cells with various degrees of malignancy after their cultivation with Lactobacillus rhamnosus, various vector mechanisms of modification of the vital activity system of malignant cells by changing their proliferative activity and initiating their apoptotic program were revealed. Key words: microbiota, Lactobacillus, breast

Keywords: microbiota, Lactobacillus, breast cancer, proliferation, apoptosis.


  1. Bhatt AP, Redinbo MR, Bultman The role of the mic- robiome in cancer development and therapy. CA Cancer J Clin 2017; 67 (4): 326–44. doi: 10.3322/caac.21398.
  2. https://theconversatcom/humans-are-8-virus-how-the- ancient-viral-dna-in-your-genome-plays-a-role-in-human- disease-and-development-192322
  3. Jeyakumar T, Beauchemin N, Gros P. Impact of the micro- biome on the human Trends in parasitology 2019; 35 (10): 809–21.
  4. Vivarelli S, Salemi R, Candido S, et al. Gut microbiota and cancer: from pathogenesis to therapy. Cancers 2019; 11 (1): doi:  10.3390/cancers11010038.
  5. Leong TL, Bryant B cells in lung cancer-not just a by- stander cell: a literature review. Transl Lung Cancer Res 2021; 10 (6): 2830–41. doi: 10.21037/tlcr-20-788.
  6. Banerjee S, Wei Z, Tian T, et al. Prognostic correlations with the microbiome of breast cancer Cell Death Dis 2021; 12: 831. doi: 10.1038/s41419-021-04092.
  7. Wang H, Altemus J, Niazi F, et al. Breast tissue, oral and urinary microbiomes in breast Oncotarget 2017; 8 (50): 88122–138. doi: 10.18632/oncotarget.21490.
  8. Banerjee S, Schlaeppi K, van der Heij MGA. Keystone taxa as drivers of microbiome structure and Nat Rev Microbiol 2018; 16 (9): 567–76. doi: 10.1038/ s41579-018-0024-1.
  9. Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: diagnostic tools and therapeutic Science 2018; 359: 1366–70. doi: 10.1126/science.aar6918.
  10. Rea D, Coppola G, Palma G, et al. Microbiota effects on can- cer: from risks to Oncotarget 2018; 9: 17915–27. doi:  10.18632/oncotarget.24681.
  11. Rajoka MSR, Zhao H, Mahreen Mehwish H, et al. Anti- tumor potential of cell free culture supernatant of Lactoba- cillus rhamnosus strains isolated from human breast milk. Food Res Int 2019; 123: 286–97. doi: 11016/j.foodres. 2019.05.002.
  12. Capurso Thirty years of Lactobacillus rhamnosus GG.J Clin Gastroenterol 2019; 53: S1–S41. doi: 10.1097/MCG. 0000000000001170.
  1. Orlando A, Messa C, Linsalata M, et al. Eff of Lac­ tobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol Immunotoxicol 2009; 31 (1): 108–16. doi: 10.1080/08923970802443631.
  1. Okajima T, Nakamura K, Zhang H, et al. Sensitive colorimet- ric bioassays for insulin-like growth factor (IGF) stimula- tion of cell proliferation and glucose consumption: use in studies of IGF Endocrinol 1992; 130 (4): 2201–12. doi: 10.1210/endo.130.4.1372238.
  2. Lykhova A, Kudryavets Yu, Strokovska L, et al. Suppres- sion of proliferation, tumorigenicity and metastasis of lung cancer cells after their transduction by interferon-beta gene in baculovirus Cytokine 2015: 71 (2): 318–26. doi: 10.1016/j.cyto.2014.10.029.
  3. Detre S, Saclani Jotti G, Dowsett A “quickscore” method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 1995; 48 (9): 876–78. doi: 10.1136/jcp.48.9.876.
  4. Salemi, R, Vivarelli, S, Ricci D, et al. Lactobacillus rhamno- sus GG cell-free supernatant as a novel anti-cancer adjuvant. J Transl Med 2023; 21: 195. doi: 10.1186/s12967-023-04036-3.
  1. Dehghani N, Tafvizi F, Jafari P. Cell cycle arrest and anti- cancer potential of probiotic Lactobacillus rhamnosus against HT-29 cancer Bioimpacts 2021; 11 (4): 245–52. doi: 10.34172/bi.2021.32.
  2. Karimi Ardestani S, Tafvizi F, Tajabadi Ebrahimi Heat- killed probiotic bacteria induce apoptosis of HT-29 human colon adenocarcinoma cell line via the regulation of Bax/ Bcl2 and caspases pathway. Hum Exp Toxicol 2019; 38 (9): 1069–81. doi: 10.1186/s12967-023-04036-3.
  3. Esfandiary A, Taherian-Esfahani Z, Abedin-Do A, et al. Lactobacilli modulate hypoxia-inducible factor (HIF)-1 regulatory pathway in triple negative breast cancer cell Cell J 2016; 18 (2): 237–44. doi: 10.22074/cellj.2016. 4319.
  4. Ćmielová J, Řezáčová Protein and its function based on a subcellular localization. J Cell Biochem 2011; 112 (12): 3502–06. doi:  10.1002/jcb.23296.



No comments » Add comment